financetom
Business
financetom
/
Business
/
GoodRx Q4 Adjusted Earnings, Revenue Rise; Q1, 2025 Revenue Guidance Issued
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GoodRx Q4 Adjusted Earnings, Revenue Rise; Q1, 2025 Revenue Guidance Issued
Feb 27, 2025 6:29 AM

09:01 AM EST, 02/27/2025 (MT Newswires) -- GoodRx Holdings ( GDRX ) reported Q4 adjusted earnings Thursday of $0.09 per diluted share, up from $0.08 a year earlier.

Analysts polled by FactSet expected $0.09.

Revenue for the quarter ended Dec. 31 was $198.6 million, up from $196.6 million a year earlier.

Analysts surveyed by FactSet expected $199.8 million.

The company expects revenue of $201 million to $205 million for Q1 and $810 million to $840 million for 2025. Analysts surveyed by FactSet expect $202.8 million and $825.2 million, respectively.

The company's shares were up 1% in premarket activity Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BXP Plans $600 Million Exchangeable Senior Notes Offering
BXP Plans $600 Million Exchangeable Senior Notes Offering
Sep 24, 2025
07:44 AM EDT, 09/24/2025 (MT Newswires) -- BXP (BXP) said Wednesday that it plans to offer $600 million of exchangeable senior notes due 2030 through its operating partnership, Boston Properties Limited Partnership. The offering is targeted at institutional buyers, with BPLP offering initial buyers a 13-day option to purchase up to an additional $90 million of notes, the company said....
Freeport-McMoRan expects lower consolidated sales for copper, gold in third quarter
Freeport-McMoRan expects lower consolidated sales for copper, gold in third quarter
Sep 24, 2025
Sept 24 (Reuters) - Miner Freeport-McMoRan said on Wednesday that it was expecting consolidated sales to be about 4% lower for copper and nearly 6% lower for gold in the third quarter, compared with its prior forecast. (Reporting by Pooja Menon in Bengaluru; Editing by Anil D'Silva) ...
Astrazeneca Says Supplemental Biologics License Application for Breast Cancer Treatment Granted US FDA's Priority Review
Astrazeneca Says Supplemental Biologics License Application for Breast Cancer Treatment Granted US FDA's Priority Review
Sep 24, 2025
07:45 AM EDT, 09/24/2025 (MT Newswires) -- Astrazeneca ( AZN ) said Wednesday the US Food and Drug Administration has granted priority review to its and Daiichi Sankyo's supplemental biologics license application for Enhertu combined with pertuzumab for the first-line treatment of adult patients with unresectable or metastatic HER2-positive breast cancer. The agency's action date for the regulatory decision is...
Two US senators urge Tinder parent to act against dating scams on its apps
Two US senators urge Tinder parent to act against dating scams on its apps
Sep 24, 2025
(Reuters) -Two U.S. senators sent a letter to Tinder parent Match on Wednesday, pushing for action against dating scams on the company's platforms and asking for information about its efforts to detect frauds and protect its users. In a letter to Match CEO Spencer Rascoff, Democratic Senator Maggie Hassan and Republican Senator Marsha Blackburn asked the company to provide documents...
Copyright 2023-2026 - www.financetom.com All Rights Reserved